{"id":87972,"date":"2026-02-16T11:14:38","date_gmt":"2026-02-16T05:44:38","guid":{"rendered":"https:\/\/vajiramandravi.com\/current-affairs\/?p=87972"},"modified":"2026-02-16T11:58:50","modified_gmt":"2026-02-16T06:28:50","slug":"refurbished-medical-devices-in-india","status":"publish","type":"post","link":"https:\/\/vajiramandravi.com\/current-affairs\/refurbished-medical-devices-in-india\/","title":{"rendered":"Refurbished Medical Devices in India: Policy Debate, Industry Divide &#038; Regulatory Challenges"},"content":{"rendered":"<h2><b>Refurbished Medical Devices Latest News<\/b><\/h2>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Recently, the Department of Pharmaceuticals informed the Rajya Sabha that the Ministry of Health and Family Welfare (MoHFW) has constituted a committee to draft a policy on the regulation of refurbished medical devices.\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">The panel will define their scope, establish methods to assess safety, performance, and remaining useful life, and recommend guidelines for disposal and waste management.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">The core debate now centres not on whether refurbished medical devices should be allowed, but on how they should be effectively regulated while <\/span><b>balancing healthcare access and industrial policy considerations<\/b><span style=\"font-weight: 400;\">.<\/span><\/li>\n<\/ul>\n<h2><b>About Refurbished Medical Devices<\/b><\/h2>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Refurbished medical devices are previously used equipment restored to original operating standards and resold at lower prices.\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">These are typically capital-intensive technologies such as MRI machines, CT scanners, PET-CT systems, advanced endoscopy units, and robotic surgical systems.<\/span><\/li>\n<\/ul>\n<h3><b>Cost Advantage Over New Equipment<\/b><\/h3>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Refurbished systems offer significant cost savings:<\/span>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">1.5T MRI machine: New: \u20b94\u20138 crore | Refurbished: \u20b91\u20133.5 crore<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">PET-CT system: New: \u20b920 crore+ | Refurbished: \u20b960 lakh\u20133.5 crore<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">CT scanner: New: \u20b92\u20134 crore | Refurbished: \u20b920 lakh\u20132.5 crore<\/span><\/li>\n<\/ul>\n<\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">These price differences make advanced diagnostics more accessible, particularly for hospitals in Tier-2 and Tier-3 cities.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">For district hospitals, standalone diagnostic centres, and smaller private facilities, refurbished equipment reduces upfront capital costs.\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">This supports decentralisation of healthcare and improves access to advanced diagnostics outside major urban centres.<\/span><\/li>\n<\/ul>\n<h3><b>Dependence on Imports<\/b><\/h3>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Despite growth in domestic manufacturing, India remains reliant on imports for advanced imaging and specialised devices due to technological complexity and global supply chain dominance.\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Refurbished equipment is commonly sourced from countries like the US, Germany, Japan, and the Netherlands, where hospitals upgrade systems before the end of their functional life.<\/span><\/li>\n<\/ul>\n<h2><b>Current Government Policy on Refurbished Medical Devices<\/b><\/h2>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">India does <\/span><b>not<\/b><span style=\"font-weight: 400;\"> have a specific regulatory pathway for refurbished medical devices under the <\/span><b>Medical Devices Rules, 2017<\/b><span style=\"font-weight: 400;\">.\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Although all medical devices were brought under phased regulation from 2017 and notified as \u201cdrugs\u201d in 2020 under the Drugs and Cosmetics Act, <\/span><span style=\"font-weight: 400;\">no separate licensing mechanism exists for refurbished products<\/span><span style=\"font-weight: 400;\">.<\/span><\/li>\n<\/ul>\n<h3><b>Imports Governed by Waste Management Rules<\/b><\/h3>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">At present, refurbished device imports are regulated primarily under the <\/span><b>Hazardous and Other Wastes (Management and Transboundary Movement) Rules, 2016<\/b><span style=\"font-weight: 400;\">.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Imports are allowed only after obtaining:<\/span>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">No-objection certificates from an expert committee under the Ministry of Environment, Forest and Climate Change (MoEFCC)<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">Technical inputs from the Central Drugs Standard Control Organisation (CDSCO)<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">Import authorisation from the Directorate General of Foreign Trade<\/span><\/li>\n<\/ul>\n<\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Earlier bans on used critical-care devices were relaxed in December 2022, permitting certain high-end equipment under strict scrutiny.<\/span><\/li>\n<\/ul>\n<h3><b>Recent Approvals and Regulatory Clash<\/b><\/h3>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">In November 2025, a MoEFCC technical committee approved several refurbished devices for reuse.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">However, in January 2025, CDSCO stated that refurbished devices <\/span><b>cannot be imported<\/b><span style=\"font-weight: 400;\"> for sale due to the absence of licensing provisions under the Medical Devices Rules.\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">This contradiction created regulatory inconsistency between environmental approvals and medical device regulation.<\/span><\/li>\n<\/ul>\n<h3><b>Policy Ambiguity and Industry Concerns<\/b><\/h3>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">India lacks a statutory definition distinguishing \u201cused,\u201d \u201crefurbished,\u201d \u201creconditioned,\u201d or \u201cremanufactured\u201d devices.\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">This creates uncertainty around classification, licensing, compliance, patient safety, and domestic manufacturing policy.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Industry estimates place the refurbished segment at around \u20b91,500 crore, nearly 10% of India\u2019s medical equipment market, highlighting the need for a coherent and unified regulatory framework.<\/span><\/li>\n<\/ul>\n<h2><b>Refurbished Medical Devices: Industry Divide and Policy Debate<\/b><\/h2>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">The absence of a clear pathway under the Medical Devices Rules has created uncertainty for both industry and policymakers.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">A key tension lies between promoting domestic manufacturing under Make in India and ensuring affordable access to advanced diagnostics, particularly in Tier-2 and Tier-3 cities.<\/span><\/li>\n<\/ul>\n<h3><b>International Manufacturers\u2019 Perspective<\/b><\/h3>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">The Medical Technology Association of India (MTAI), representing global manufacturers, argues against a blanket ban.\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">It maintains that refurbished devices are regulated globally rather than prohibited.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">It contends that regulated imports can improve affordability, expand access, support healthcare training goals, and complement industrial initiatives such as Electronics Repair Services Outsourcing.<\/span><\/li>\n<\/ul>\n<h3><b>Domestic Manufacturers\u2019 Concerns<\/b><\/h3>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">The Association of Indian Medical Device Industry (AiMeD) strongly opposes easing restrictions without robust regulatory standards aligned with global benchmarks.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Domestic players argue refurbished devices carry risks of <\/span><b>unclear usage history<\/b><span style=\"font-weight: 400;\">, inconsistent performance, limited traceability, and shorter lifespan.\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">They warn that legalising such imports could undermine indigenous manufacturing, weaken emergency preparedness, and turn India into a destination for end-of-life equipment.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Industry estimates suggest that unauthorised trade in pre-owned equipment is already significant, raising oversight and compliance concerns.<\/span><\/li>\n<\/ul>\n<h3><b>Impact on Innovation and Industrial Policy<\/b><\/h3>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Critics highlight that in developed countries, hospitals upgrade equipment after around 10 years, with older systems refurbished for resale.\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">When such systems compete at similar price points with new Indian-made products, they may discourage domestic investment in advanced medical technologies.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">This raises broader questions about <\/span><b>balancing healthcare affordability with long-term industrial growth and innovation capacity<\/b><span style=\"font-weight: 400;\">.<\/span><\/li>\n<\/ul>\n<p><b>Source:<\/b> <strong><a href=\"https:\/\/indianexpress.com\/article\/explained\/explained-health\/refurbished-medical-devices-india-global-vs-domestic-10530125\/\" target=\"_blank\" rel=\"nofollow noopener\">IE<\/a><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Refurbished Medical Devices in India spark debate over regulation, safety, imports, and Make in India. Here\u2019s how policy gaps impact healthcare access and industry growth.<\/p>\n","protected":false},"author":18,"featured_media":87987,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[18],"tags":[60,5450,22,59],"class_list":{"0":"post-87972","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-upsc-mains-current-affairs","8":"tag-mains-articles","9":"tag-refurbished-medical-devices","10":"tag-upsc-current-affairs","11":"tag-upsc-mains-current-affairs","12":"no-featured-image-padding"},"acf":[],"_links":{"self":[{"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/posts\/87972","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/users\/18"}],"replies":[{"embeddable":true,"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/comments?post=87972"}],"version-history":[{"count":5,"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/posts\/87972\/revisions"}],"predecessor-version":[{"id":88014,"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/posts\/87972\/revisions\/88014"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/media\/87987"}],"wp:attachment":[{"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/media?parent=87972"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/categories?post=87972"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/tags?post=87972"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}